Trial Profile
Pharmacokinetics of Liposomal Amphotericin B (AmBisome) Given Intravenously to Patients Undergoing Bariatric Surgery
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Feb 2022
Price :
$35
*
At a glance
- Drugs Amphotericin B liposomal (Primary)
- Indications Obesity
- Focus Pharmacokinetics
- Acronyms ASPEN
- 07 Sep 2019 Results published in the Clinical Infectious Diseases
- 08 Nov 2018 Status changed from recruiting to completed.
- 11 Apr 2018 Status changed from not yet recruiting to recruiting.